{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["22(1)"],"submitter":["Kaida H"],"pubmed_abstract":["<h4>Background</h4>Induction or adjuvant therapies are not always beneficial for thoracic esophageal squamous cell carcinoma (ESCC) patients, and it is thus important to identify patients at high risk for postoperative ESCC recurrence. We investigated the usefulness of the total metabolic tumor volume (TMTV) for predicting the postoperative recurrence of thoracic ESCC.<h4>Methods</h4>We retrospectively analyzed the cases of 163 thoracic ESCC patients (135 men, 28 women; median age of 66 [range 34-82] years) treated at our hospital in 2007-2012. The TMTV was calculated from the fluorine-18 fluorodeoxyglucose (<sup>18</sup>F-FDG) uptake in the primary lesion and lymph node metastases. The optimal cut-off values for relapse and non-relapse were obtained by the time-dependent receiver operatin"],"journal":["BMC cancer"],"pagination":["1176"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9664655"],"repository":["biostudies-literature"],"pubmed_title":["The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma."],"pmcid":["PMC9664655"],"pubmed_authors":["Kato H","Kimura Y","Tsurusaki M","Ishii K","Kaida H","Hanaoka K","Matsukubo Y","Hattori S","Yasuda T","Yamada M","Shiraishi O","Kitajima K"],"additional_accession":[]},"is_claimable":false,"name":"The usefulness of the total metabolic tumor volume for predicting the postoperative recurrence of thoracic esophageal squamous cell carcinoma.","description":"<h4>Background</h4>Induction or adjuvant therapies are not always beneficial for thoracic esophageal squamous cell carcinoma (ESCC) patients, and it is thus important to identify patients at high risk for postoperative ESCC recurrence. We investigated the usefulness of the total metabolic tumor volume (TMTV) for predicting the postoperative recurrence of thoracic ESCC.<h4>Methods</h4>We retrospectively analyzed the cases of 163 thoracic ESCC patients (135 men, 28 women; median age of 66 [range 34-82] years) treated at our hospital in 2007-2012. The TMTV was calculated from the fluorine-18 fluorodeoxyglucose (<sup>18</sup>F-FDG) uptake in the primary lesion and lymph node metastases. The optimal cut-off values for relapse and non-relapse were obtained by the time-dependent receiver operatin","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Nov","modification":"2025-04-21T17:10:25.42Z","creation":"2025-04-21T17:10:25.42Z"},"accession":"S-EPMC9664655","cross_references":{"pubmed":["36376801"],"doi":["10.1186/s12885-022-10281-4"]}}